Trypanosoma cruzi, cancer and the Cold War
Bibliographic Data
| ID | 3101889 |
|---|---|
| Authors | Nikolai Krementsov (0000-0001-8839-5948, University of Toronto, corresponding author) |
| Year | 2009 |
| Volume | 16 |
| Issue | suppl 1 |
| Pages | 75-94 |
| Publication date | 2009-07-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | História Ciências Saúde-Manguinhos (JOURNAL) |
| Journal identifiers | ISSN: 0104-5970 • E-ISSN: 1678-4758 |
| Publisher | FapUNIFESP (SciELO) (PUBLISHER) |
| DOI | 10.1590/s0104-59702009000500005 |
| PMID | 20027919 |
| OpenAlex | W2142834315 |
| SCIELO_PID | S0104-59702009000500005 |
| Language | EN |
| Citations received | 2 |
| References cited | 18 |
In the summer of 1946, the international community of cancer researchers was inspired by the announcement that two Soviet scientists, Nina Kliueva and Grigorii Roskin, had discovered anticancer properties in culture extracts made from the South American protozoan, Trypanosoma cruzi, and had produced a preparation - named after its discoverers KR - which showed clear therapeutic effects on cancer patients. Research teams from various countries enthusiastically pursued the promising new line of investigation. The story of the rise and fall of interest in the anticancer properties of T. cruzi in different countries suggests that during the second half of the twentieth century, the Cold War competition between the superpowers played an important role in shaping the research agendas of cancer studies
Biology · Cancer · Cold war · Competition (biology) · Development economics · Economics · Political science · Trypanosoma cruzi · Biochemical and Molecular Research · Ecology · History · Internal Medicine · Law · Medicine · Trypanosoma species research and implications
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,13 |
| Citation span | 2011 - 2014 (4) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |